Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Non-invasive assessment of portal hypertension and carvedilol response in cirrhosis
2011-001132-30Phase 4Completed
- Sponsor
- General University Hospital in Prague
- Start
- Apr 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of carvedilol in Portal Hypertension (PH) and Cirrhosis, sponsored by General University Hospital in Prague. Primary endpoints: Treatment efficacy, Association of beta-2 adrenergic receptor polymorphisms with treatment response and 1 more. Started Apr 2011; status: completed.
02
Drugs
carvedilol
03
Conditions
Portal Hypertension (PH)Cirrhosis
Beyond the preview
Go deeper on 2011-001132-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-001132-30.